Cargando…

Decrease in outpatient department visits and operative interventions due to bisphosphonates in children with osteogenesis imperfecta

INTRODUCTION: Bisphosphonates are currently the medical treatment most often used in children with osteogenesis imperfecta (OI). The purpose of this retrospective pre–post study was to evaluate the efficacy of treatment with bisphosphonates. We measured the effect by evaluating the number of outpati...

Descripción completa

Detalles Bibliográficos
Autores principales: de Graaff, F., Verra, W., Pruijs, J. E. H., Sakkers, R. J. B.
Formato: Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058211/
https://www.ncbi.nlm.nih.gov/pubmed/21594080
http://dx.doi.org/10.1007/s11832-010-0305-3
_version_ 1782200354836840448
author de Graaff, F.
Verra, W.
Pruijs, J. E. H.
Sakkers, R. J. B.
author_facet de Graaff, F.
Verra, W.
Pruijs, J. E. H.
Sakkers, R. J. B.
author_sort de Graaff, F.
collection PubMed
description INTRODUCTION: Bisphosphonates are currently the medical treatment most often used in children with osteogenesis imperfecta (OI). The purpose of this retrospective pre–post study was to evaluate the efficacy of treatment with bisphosphonates. We measured the effect by evaluating the number of outpatient department consultations and operative interventions before and after treatment with bisphosphonates in children with OI. METHODS AND MATERIALS: Outpatient department consultation and operative intervention frequencies before and after treatment with bisphosphonates were registered. Children who had at least 2 years of medical records before treatment and at least 2 years after treatment were used in this study. RESULTS: Of 118 children who were treated with bisphosphonates, 51 (23 boys and 28 girls) fulfilled the inclusion criteria. Statistical analysis revealed a significant decrease in outpatient department consultations (P < 0.000) and operative intervention (P < 0.003) before and after bisphosphonate treatment. CONCLUSION: The pre-post design of our study shows a significant reduction of the number of outpatient department consultations and operative interventions in patients with OI after treatment with bisphosphonates.
format Text
id pubmed-3058211
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-30582112011-04-05 Decrease in outpatient department visits and operative interventions due to bisphosphonates in children with osteogenesis imperfecta de Graaff, F. Verra, W. Pruijs, J. E. H. Sakkers, R. J. B. J Child Orthop Original Clinical Article INTRODUCTION: Bisphosphonates are currently the medical treatment most often used in children with osteogenesis imperfecta (OI). The purpose of this retrospective pre–post study was to evaluate the efficacy of treatment with bisphosphonates. We measured the effect by evaluating the number of outpatient department consultations and operative interventions before and after treatment with bisphosphonates in children with OI. METHODS AND MATERIALS: Outpatient department consultation and operative intervention frequencies before and after treatment with bisphosphonates were registered. Children who had at least 2 years of medical records before treatment and at least 2 years after treatment were used in this study. RESULTS: Of 118 children who were treated with bisphosphonates, 51 (23 boys and 28 girls) fulfilled the inclusion criteria. Statistical analysis revealed a significant decrease in outpatient department consultations (P < 0.000) and operative intervention (P < 0.003) before and after bisphosphonate treatment. CONCLUSION: The pre-post design of our study shows a significant reduction of the number of outpatient department consultations and operative interventions in patients with OI after treatment with bisphosphonates. Springer Berlin Heidelberg 2011-01-25 2011-04 /pmc/articles/PMC3058211/ /pubmed/21594080 http://dx.doi.org/10.1007/s11832-010-0305-3 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is published under license to BioMed Central Ltd. Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Original Clinical Article
de Graaff, F.
Verra, W.
Pruijs, J. E. H.
Sakkers, R. J. B.
Decrease in outpatient department visits and operative interventions due to bisphosphonates in children with osteogenesis imperfecta
title Decrease in outpatient department visits and operative interventions due to bisphosphonates in children with osteogenesis imperfecta
title_full Decrease in outpatient department visits and operative interventions due to bisphosphonates in children with osteogenesis imperfecta
title_fullStr Decrease in outpatient department visits and operative interventions due to bisphosphonates in children with osteogenesis imperfecta
title_full_unstemmed Decrease in outpatient department visits and operative interventions due to bisphosphonates in children with osteogenesis imperfecta
title_short Decrease in outpatient department visits and operative interventions due to bisphosphonates in children with osteogenesis imperfecta
title_sort decrease in outpatient department visits and operative interventions due to bisphosphonates in children with osteogenesis imperfecta
topic Original Clinical Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058211/
https://www.ncbi.nlm.nih.gov/pubmed/21594080
http://dx.doi.org/10.1007/s11832-010-0305-3
work_keys_str_mv AT degraafff decreaseinoutpatientdepartmentvisitsandoperativeinterventionsduetobisphosphonatesinchildrenwithosteogenesisimperfecta
AT verraw decreaseinoutpatientdepartmentvisitsandoperativeinterventionsduetobisphosphonatesinchildrenwithosteogenesisimperfecta
AT pruijsjeh decreaseinoutpatientdepartmentvisitsandoperativeinterventionsduetobisphosphonatesinchildrenwithosteogenesisimperfecta
AT sakkersrjb decreaseinoutpatientdepartmentvisitsandoperativeinterventionsduetobisphosphonatesinchildrenwithosteogenesisimperfecta